IMU-856 Restores Gut Barrier Function, Key for Halting IBD Progression, Preclinical Data Suggests
News
The oral small molecule IMU-856, now being developed by Immunic Therapeutics, strengthens and improves the barrier function of intestinal cells while having little to no effect on the immune system, preclinical ... Read more